SUNPHARMA1,850.00

Sun Pharmaceutical Industries Ltd.

· Pharma & Health
₹ CrorePeersCIPLADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹4.44L Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+11.2+9.8
EBITDA+16.1+16.7
Net Income+5.0+9.4
EPS (adj.)+5.0+9.5
Total Assets+18.1+12.8
Total Equity+15.7+11.8
Free Cash Flow-26.2-5.8
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 199%.